The small GTPases Ras and Rap1 bind to and control TORC2 activity

Ankita Khanna1, Pouya Lotfi2, Anita J Chavan2

  • 1Department of Cell Biochemistry, University of Groningen, Groningen, 9747AG, Netherlands.

Scientific Reports
|May 14, 2016
PubMed

Insights

Scientists identified Rap1 as a key regulator of Target of Rapamycin Complex 2 (TORC2) signaling. This discovery reveals how Rap1 and RasC pathways cooperate to control cell migration and TORC2 activity.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Target of Rapamycin Complex 2 (TORC2) is crucial for cytoskeleton dynamics and cell migration, with implications in cancer metastasis.
  • Mechanisms governing TORC2 activity and function remain largely unelucidated.
  • In Dictyostelium, TORC2 regulates F-actin dynamics and cAMP production at the leading edge of migrating cells, downstream of RasC.

Purpose of the Study:

  • To identify novel regulators of TORC2 activity and function.
  • To elucidate the mechanism of TORC2 activation in directed cell migration.
  • To understand the interplay between Ras and Rap1 signaling pathways in controlling TORC2.

Main Methods:

  • Identification of binding partners for the TORC2 component RIP3/SIN1 using biochemical assays.
  • Investigation of the role of Rap1 in regulating TORC2 activity in response to RasC.
  • Analysis of the interaction between active RasC and the catalytic domain of TOR.

Main Results:

  • The small GTPase Rap1 was identified as a conserved binding partner of RIP3/SIN1.
  • Rap1 was found to positively regulate RasC-mediated activation of TORC2 in Dictyostelium.
  • Active RasC was shown to bind to the catalytic domain of TOR, suggesting a conserved activation mechanism.

Conclusions:

  • Rap1 is a novel regulator of TORC2, working in concert with RasC to control cell migration.
  • The findings suggest a mechanism for TORC2 activation involving direct binding of active RasC to the TOR catalytic domain.
  • Dual regulation by Ras and Rap1 allows for the integration of signaling pathways essential for directed cell migration.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
10.3K
GTPases and their Regulation02:14

GTPases and their Regulation

3.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K